FDA’s ANDA Prioritization Pilot: The Next Step in the Domestic Production Shift
By: Caitlin A. Koppenhaver, In our last article, FDA’s Expanding Focus from RUO Platforms to Mainstream Oversight, we shared how the Agency is moving beyond traditional enforcement to reshape how and